4//SEC Filing
Dunsire Deborah 4
Accession 0000950170-24-068759
CIK 0001556263other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:42 PM ET
Size
6.9 KB
Accession
0000950170-24-068759
Insider Transaction Report
Form 4
Dunsire Deborah
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-06-01−4,000→ 0 total→ Common Stock (4,000 underlying) - Exercise/Conversion
Common Stock
2024-06-01+4,000→ 12,000 total
Footnotes (3)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit ("RSU") award.
- [F2]Each RSU represents the contingent right to receive one share of the issuer's common stock.
- [F3]These RSUs vested in their entirety on the first anniversary of the date of grant of the award.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001332764
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 4:42 PM ET
- Size
- 6.9 KB